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1. Introduction 
Metallothioneins are sulfur-rich proteins first recog- 
nized in equine and human renal cortex by their un- 
usual content of cadmium [ 1,2] . All preparations con- 
tained in addition, however, equally appreciable 
amounts of zinc and the variations in the relative 
amounts of the two metals suggested even in the earli- 
est studies that they may replace each other. A natural- 
ly occurring only zinc-containing form of metallothio- 
nein was recently identified in equine liver and recog- 
nized as one of the major zinc proteins of this organ 
[3,4] . In the present study we report the isolation 
from human liver and characterization of two similar, 
only zinc-containing forms of metallothionein. 
2. Material and methods 
2.1. Extraction procedure 
Human livers were obtained from adult patients of 
both sexes who had died of causes other than hepatic 
disease. From each liver an extract was made by buffer 
extraction and solvent fractionation using a modifica- 
tion of the method described for the isolation of hu- 
man renal metallothionein [2] . In the new procedure 
the dialysis step employed previously was omitted and 
a second solvent fractionation step involving the addi- 
tion of 2 parts of 95% ethanol, prechilled to -2O”C, 
was introduced to precipitate the metalloprotein frac- 
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tion. The white precipitate formed was collected by 
centrifugation (3000 g, 20 min) and reextracted for 
10 min with 200 ml H,O. After removal of insoluble 
material by centrifugation (20 OOOg, 2 hr) the super- 
natant was lyophilized. 
2.2. Chromatographic procedures 
Sephadex G-75 and DEAE-Sephadex A-25 were 
products of Pharmacia, Uppsala, Sweden, and were 
prepared for use by equilibration with the buffer solu- 
tions employed. Gel filtration and ion exchange chro- 
matography were carried out at 4°C in 150 X 4.5 cm 
and 13 X 1.5 cm columns respectively. Further details 
of the chromatographic procedures are given in fig. 1. 
Following chromatography pooled fractions were de- 
salted and concentrated by ultrafiltration at 4°C in an 
Amicon pressure dialyzer equipped with an UM-2 
membrane (Amicon N.V., Oosterhout (N.B.), Holland). 
2.3. Metal analyses 
Metal analyses were performed with an Instrumen- 
tation Laboratory IL-353 atomic absorption spectro- 
photometer after appropriate dilution of the samples 
in water. 
2.4. Amino acid analyses 
Amino acid analyses were carried out on samples 
oxidized with performic acid for 16 hr [ 51 and hydro- 
lyzed in evacuated and sealed tubes in 6 N HCl for 22 
hr [6] . Measurements were made on a Beckman 
Spinco amino acid analyzer, Model 120 B. Cysteic 
acid and methionine sulfone were determined using 
the calibration constants for aspartic acid and methio- 
nine, respectively. Values for serine and threonine were 
corrected for standard losses. Tyrosine and tryptophan 
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Fig. i. Chromato~aphic separation of multiple forms of human hepatic met~lo~ionein, Zinc (-), cadmium (- - -) and absor- 
bance at 280 nm (.*.a.) are measured. The brackets denote effluent fractions pooled for further processing. A. Gel filtration of lyo- 
philized extract of a single human liver on Sephadex G-75 in 0.02 M Tris-0.005 M HCI, pH 8.6. Flow rate: 65 ml/hr; B. Gradient 
ion exchange chromatography of main zing-contain~g peak of fig. A on DEAESephadex A-25 equilibrated with 0.02 M Tris- 
0.005 M HCl, pH 8.6, as starting buffer. Elution is carried out by passing through the columns SO ml of starting buffer followed 
by a 140 ml linear salt gradient and 70 ml limit buffer (0.2 M Tris-0.05 M HCl, pH 8.6). Flow rate: 14 ml/hr; C. Rechromatog- 
raphy of concentrated and desalted fraction 3 of fig. B on DEAE-Sephadex A-25 equilibrated with 0.03 M Tris-0.0075 M HCl, 
pH 8.6. Elution is carried out with the same buffer without gradient. Flow rate: 15.5 ml/hr. The material pooled is designated 
metallothionein 1 (= MT-l); D. Rechromatography of concentrated and desalted fraction 4 of fig. B on DEAE-Sephadex A-25 
equ~ibrated with 0.03 M Tris-0.0075 M HCI, pH 8.6. Eiution is carried out by passing through the column 1200 ml of the same 
buffer followed by 1000 ml 0.06 M Tris-0.015 M HCI, pH 8.6, Flow rate: 15.5 mI/hr. The material pooled is designated metallo- 
thionein 2 (= MT-2). 
were measured spectrophotometrically in the non-oxi- 
dized protein. The minimum molecular weight was 
determined by the statistical method of Defaage [7] . 
2.5. Protein co~~e~trat~5~s 
Protein concentrations were evaluated from quanti- 
tative amino acid analysis data. 
2.6. Reactive mercapto groups 
Reactive mercapto groups were determined by titra- 
tion with DTNB in 6.0 M guanidine-HCI, pH 8.0, con- 
taining 50 mM EDTA [8] . 
2.7. Polyacrylamide disc gel electrophoresis 
Polyac~lamide disc gel electrophoresis was carried 
out at a constant current of 4 mA per tube and approx- 
imately 200 V for two hr at 23°C [9]. 
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2.8. Molecular weights 
Molecular weights were estimated by the gel fitra- 
tion method of Fish et al. [IO] on samples oxidized 
with performic acid using a 90 X 1.5 cm column 
packed with Biogel A-5 m, 50-100 mesh, equilibrated 
with 6.0 M guanidine-HCl (Schwarz/Mann, Orangeburg, 
N.Y., USA). The partition coefficients KD were evalu- 
ated from the relationship 
ve-v 
KDD=vt-v, 
where Ve is the elution volume of the unknown sam- 
ple, V, the void volume and V, the total volume. As 
marker proteins were employed: Pancreatic ribonu- 
clease, mol. wt. I3 700 (Calbiochem); trypsin inhibitor 
from Lima bean, Type II-L, mol. wt. 8400 (Sigma); 
insulin, oxidized B-chain, mol. wt. 3500; insulin, oxi-, 
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Fig. 2. Polyacrylamide disc gel electrophoresis of main metallo- 
thionein fractions. Left: MT-1 ; right: MT-2. 
dized A-chain, mol. wt. 2500 (Mann Research 
Laboratories). 
3. Results 
The isolation of zinc-containing proteins from the 
lyophilized extract of human liver is documented in 
fig. IA-D. By gel filtration of the extract on Sephadex 
G-75 two zinc-containing fractions are separated (fig. 
1A). The larger one is characterized also by the pres- 
ence of small amounts of cadmium. By gradient ion 
exchange chromatography on DEAE-Sephadex A-25 
this material is resolved into five metal-containing frac- 
tions (fig. 1 B). Peaks 3 and 4 are further purified by 
rechromatography on DEAE-Sephadex A-25 without 
gradient (fig. 1 C, 1 D). The resulting metal-containing 
fractions exhibit low absorbance at 280 nm and were 
recognized by their chemical properties (vide infra) as 
Table 1 
Metal content of human liver metallothioneins (referred to 
weight of metal-free protein). 
MT-l MT-2 
% % 
Zinc 6.26 7.58 
Cadmium 0.14 0.19 
Copper 0.13 0.07 
Total 6.53 7.84 
variants of metallothionein isolated previously from 
human kidney [2] . They are designated as human he- 
patic metallothionein 1 (= MT-l) and metallothionein 
2 (= MT-2) respectively. The total yield from one liver 
ranges for each form between 50 and 100 mg. 
Both protein fractions are homogenous as judged 
by the appearance of a single stainable band on poly- 
acrylamide disc electrophoresis (fig. 2). They differ, 
however, in electrophoretic mobility, MT-2 moving 
faster towards the anode than MT-l. On the other 
hand, both proteins are closely similar in size as judged 
by their identical behaviour on gel filtration on a 200 
cm Sephadex G-50 column. 
The metal contents are summarized in table 1. MT- 
2 contains substantially more metal than MT-l. In 
both proteins zinc is the predominant metallic species 
(> 95%). It is accompanied by only small amounts of 
cadmium and copper. 
The amino acid composition of the two forms of 
metallothionein is also similar (table 2). The most dis- 
tinctive common features are the abundance of Cys 
and the total absence of aromatic amino acids as well 
as of His and Arg. Differences occur, however, in a 
number of amino acids. Thus, MT-1 contains more 
Glu, Val and Leu but less Cys, Asp and Ala than MT-2. 
Titration of mercapto groups in both proteins is in 
close agreement with the number of Cys suggesting 
the absence of disulfide bonds. 
The number of amino acid residues listed in table 
2 is based on the minimum molecular weight of the 
peptide chains calculated from amino acid analysis 
data, i.e. 6113 for MT-l and 6136 for MT-2. A similar 
value for the chain weight is obtained experimentally 
by gel filtration of performic acid oxidized MT-l in 
6 M guanidine-HCl using proteins of known molecular 
weight as standards (fig. 3). If the metal is included 
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Table 2 
Amino acid composition of human liver metallothioneins *. 
Amino 
acid 
LYS 
ASP 
Thr 
Ser 
Glu 
PI0 
ClY 
:+ 
Val 
Mettt 
Be 
Leu 
7.80 8 
2.89 3 
2.45 2 
8.40 8 
3.42 3 
2.40 2 
4.87 5 
5.76 6 
18.50 18 
2.14 2 
0.83 1 
1.18 1 
0.68 1 
7.78 8 
4.06 4 
2.08 2 
8.30 8 
2.39 2 
2.07 2 
5.14 5 
6.81 7 
20.55 21 
1.12 1 
0.87 1 
0.95 1 
- 
Total* 61.32 62.12 
Mercapto 
groups** 17.45 21.61 
MT-1 MT-2 
Number Nearest Number Nearest 
of 
residues 
** integral of 
number residues 
*** integral 
number 
- 
* Average of 4 analyses. 
** Based on the minimum molecular weight 6 113. 
*** Based on the minimum molecular weight 6136. 
t Measured as cysteic acid. 
tt Measured as methionine sulfone. 
* Arg, His, Phe, Tyr and Trp were not found. 
# Measured in the intact protein. 
the minimum molecular weight of the native proteins 
is about 6600. 
Based on the chain molecular weight MT-1 contains 
a total of 6 and MT-2 a total of 7 metal atoms (table 
3). This difference in stoichiometry is proportionate 
to the difference in the numbers of Cys measured by 
amino acid analysis and of mercapto groups titrated 
in the intact proteins (table 2). Hence, their ratio to 
the number of metal atoms bound is the same in both 
proteins. For each metal atom bound there are three 
cysteinyl groups available. 
4. Discussion 
The present data demonstrate that metallothionein 
is a normal and abundant component of adult human 
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Fig. 3. Determination of chain molecular weight of performic 
acid oxidized MT-l by gel filtration in 6 M guanidinium-HCl 
on Biogel A-5 m. The molecular weight corresponsing to the 
measured partition coefficient (= 0.59) is 6500. Taking into 
account an estimated increase in molal volume of 5% on oxi- 
dation the molecular weight of the non-oxidized chain is 
close to 6200. 
liver. The two proteins which were isolated by a com- 
bination of methods previously employed in the prep- 
aration of renal metallothioneins are by most criteria 
identical with the human renal protein [2] . The oc- 
currence of more than one form of hepatic metallo- 
thionein is also typical for these proteins as shown 
previously in human and equine kidney cortex [2,1 I] 
and in rabbit and rat liver [ 12,131. 
Table 3 
Stoichiometry of metal* and cysteine in human liver metallo- 
thioneins. 
MT-1 
moles/mole 
MT-2 
moles/mole 
Metal Protein** 6.05 
C&s*** Metal 3.06 2.84 
Mercapto groups Metal 2.89 2.99 
* Sum of Zn, Cd and Cu. 
** Based on minimum molecular weights (see table 2). 
*** Measured as cysteic acid by amino acid analysis. 
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Unlike the human renal metallothioneins which 
contain both zinc and cadmium in about equal pro- 
portions both liver proteins contain zinc as their sole 
significant metallic constituent (table 1). Their zinc 
content of 6.3% and 7.6% is the highest of any known 
zinc metalloprotein comparable only with the total 
metal content of certain ferredoxins [ 141 and of fer- 
ritin. The total amount of zinc bound to metallothio- 
nein in liver represents S- 10% of the total zinc of the 
organ. 
Both hepatic metallothioneins have minimum mo- 
lecular weights close to the value of 6600 measured 
for native equine renal metallothionein by sedimenta- 
tion equilibrium centrifugation [4]. The values are 
also in agreement with amino acid analysis data re- 
ported for rabbit liver metallothionein [ 121. The 
amino acid composition of the two hepatic proteins 
also resembles that of metallothionein from other 
sources [ 3,4,12,15,16] . Their most striking common 
feature is their extreme content of Cys ranging from 
30 to 35% and the total absence of His and of aromat- 
ic amino acid residues. A feature shared with the rat 
and rabbit proteins but not with the equine metallo- 
thioneins is the absence of Arg. The differences of 
MT-1 and MT-2 in six amino acid residues reveal ap- 
preciable variation in the primary structure of the two 
proteins. Sequence studies currently in progress in this 
laboratory have identified some substitutions and 
have localized the position of the three additional Cys 
in MT-2. These studies have also given evidence for a 
marked microheterogeneity in MT-l, a feature ac- 
counting for the substantial deviations of the amino 
acid composition of this protein from integral values 
(table 2). 
The abundance of cysteine residues offers an ob- 
vious explanation for the zinc binding capacity of me- 
tallothionein. The stoichiometric relationship of three 
mercapto groups for each metal atom bound is identi- 
cal in both MT-I and MT-2 (table 3). The same ratio 
of mercapto groups to metal, although the metals vary, 
is found in all preparations of metallothionein ex- 
amined thus far [2,3,1 l] and thus appears to be a 
fundamental feature of their structure. It suggests that 
each metal binding site is composed of three mercapto 
groups, a conjecture also supported by spectroscopic 
studies [3,11,17] . As a consequence of this stoichio- 
metry each of the polymercaptide complexes formed 
between Zn2+ and three mercaptide ligands should be 
negatively charged and thus contribute to the total 
charge of the protein. It seems likely, in fact, that 
the larger negative charge of MT-2 as compared to 
MT-l (fig. 2) is due to its additional metal binding 
site. 
The biological function of metallothionein is not 
known although some evidence for its participation 
in cadmium detoxification is available [ 12,181. The 
discovery of solely zinc-containing forms of metallo- 
thionein in the present study and in previous work 
on equine liver [3,4] , suggests, however, that at least 
in liver the primary biological role of metallothionein 
must be sought in relation to this metal. An involve- 
ment in zinc transport, storage or detoxification are 
equally plausible possibilities since no physiological 
system performing such functions for zinc has been 
identified as yet. Recent reports that in rat liver me- 
tallothionein is synthesized in response to parenteral 
administration of zinc also give credence to a specific 
role in the metabolism of zinc [ 19,201. 
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